Actively Recruiting
Studying Immune System Changes and Risk of Pneumonia in Mechanically Ventilated Adults and Elderly Patients
Led by Hospital Universitari de Bellvitge · Updated on 2026-05-19
170
Participants Needed
1
Research Sites
9 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how a weakened innate immune response, called immunoparalysis, may contribute to the development of ventilator-associated pneumonia VAP in critically ill patients who require mechanical ventilation. This observational study includes three groups elderly patients aged 65 and older, younger adults under 65, and healthy volunteers. The study aims to understand how immunoparalysis affects the risk and severity of VAP and other infections in the intensive care unit ICU. The study observes patients who are critically ill and mechanically ventilated for more than 48 hours. Elderly and younger adult patients are followed over time to assess immune function through tests measuring monocyte HLA-DR expression and TNF-alpha production after stimulation. Healthy volunteers provide baseline immune data at one time point. Researchers will compare immune responses across groups and track clinical outcomes. Participants will be monitored during their ICU stay with blood samples taken at baseline, 24 hours, day 3, and day 5 after intubation to measure immune markers. Clinical data including infection rates, duration of mechanical ventilation, organ failure scores, and mortality up to 28 or 90 days will be collected. The study seeks to link immune changes with infection risk and outcomes, providing insights into the role of immunoparalysis in ICU patients.
CONDITIONS
Brief Title
Innate Immune Immunoparalysis and Ventilator-Associated Pneumonia in Critically Ill Elderly Patients
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here